Direct-acting antivirals
64 articles
Antiviral Therapy Reduces Risk of Cardiovascular Outcomes in Patients with HCV
Use of antiviral therapy is linked to a decreased risk of multiple cardiovascular outcomes and mortality compared to patients not using antiviral therapy. More
Age, Baseline Fibrosis Can Predict Fibrosis Regression with DAA Use
Fibrosis regression is prevalent among 57% of the cohort and is associated with older age and advanced fibrosis at baseline. More
Community-Based, Point-of-Diagnosis Hepatitis C Treatment Improves Outcomes
Researchers at the University of California, San Francisco, report positive results from the No One Waits study. More
Scale-Up of Direct-Acting Antiviral Treatment in Prisons is Both Cost-Effective and Key to HCV Elimination
A study in Australia evaluated the cost-effectiveness of scaling-up HCV treatment in state-wide prison services incorporating long-term outcomes across custodial and community settings. More
Barriers to a Cure: Study Reveals Global Obstacles to Getting Hep C Treatment
A study provides new evidence regarding the registration and reimbursement of HCV therapies, including restrictions on reimbursement, permitting multicountry analyses and highlighting areas for growth. More
